Rituximab for TTP.
Scott
Sarah M
SM
Szczepiorkowski
Zbigniew M
ZM
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D017353:Gene Deletion; D006801:Humans; D008666:Metalloendopeptidases / Q000172:deficiency / Q000235:genetics; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000235:genetics; D000069283:Rituximab; D014841:von Willebrand Factor / Q000235:genetics
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D014841:von Willebrand Factor; D000069283:Rituximab; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human